Pascal Soriot

Pfizer-AstraZeneca deal is not inevitable: Pascal Soriot

Pfizer's takeover bid for AstraZeneca is not inevitable and the Anglo-Swedish pharmaceutical giant can create value for its shareholder on its own, according to AstraZeneca CEO Pascal Soriot's claims.

Companies: 
General: 
People: 
Subscribe to RSS - Pascal Soriot